Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.
- DOI
- 10.1016/j.jcyt.2025.08.005
- Published
- 2025 Dec
- Container
- Cytotherapy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcyt.2025.08.005,
title = {Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.},
author = {Hwang WYK and Bari S and Kawamata S and Choi B and Koaykul C and Huang H and Gupta P},
year = {2025},
journal = {Cytotherapy},
doi = {10.1016/j.jcyt.2025.08.005},
url = {https://doi.org/10.1016/j.jcyt.2025.08.005}
}RIS
TY - JOUR TI - Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability. AU - Hwang WYK AU - Bari S AU - Kawamata S AU - Choi B AU - Koaykul C AU - Huang H AU - Gupta P PY - 2025 JO - Cytotherapy DO - 10.1016/j.jcyt.2025.08.005 UR - https://doi.org/10.1016/j.jcyt.2025.08.005 ER -
APA
WYK, H., S, B., S, K., B, C., C, K., H, H., & P, G. (2025). Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.. Cytotherapy. https://doi.org/10.1016/j.jcyt.2025.08.005
Source records
- pubmed · retrieved 2026-09-26T01:41:56.597Z
- europe-pmc · retrieved 2026-09-26T01:41:56.618Z